VAMLA, or Video-Assisted Mediastinoscopic Lymphadenectomy, is a minimally invasive surgical procedure used to remove mediastinal lymph nodes through an incision in the lower neck. The mediastinum is the central part of the chest located between the lungs and contains important structures, including the heart, major blood vessels, airways, and lymph nodes.
VAMLA is primarily associated with the surgical management and staging of non-small cell lung cancer (NSCLC). By allowing surgeons to remove multiple groups of mediastinal lymph nodes, the procedure provides tissue samples that can be examined by a pathologist to determine whether cancer has spread beyond the lung.
Accurate lymph node assessment is an important part of determining the stage of lung cancer and selecting an appropriate treatment strategy.
How Does VAMLA Work?
During VAMLA, the patient is placed under general anesthesia. The surgeon makes a small incision at the base of the neck and introduces a specialized mediastinoscope into the mediastinum.
A video camera attached to the instrument provides an enlarged view of the surgical area. Specialized instruments can then be used to carefully dissect and remove targeted lymph nodes.
Unlike conventional mediastinoscopy, which is generally performed to obtain selected lymph-node biopsies, VAMLA is designed to facilitate a more extensive mediastinal lymphadenectomy. This allows surgeons to remove lymph nodes from multiple relevant stations for detailed pathological examination.
The procedure is performed with careful attention to nearby structures, including major blood vessels, the trachea, esophagus, and recurrent laryngeal nerves.
Why Is VAMLA Performed?
One of the main reasons VAMLA is performed is to establish the extent of lung cancer spread to the mediastinal lymph nodes.
Lung cancer can spread from the primary tumor to nearby lymph nodes before progressing to more distant parts of the body. Imaging studies such as CT and PET scans can identify lymph nodes that appear suspicious, but imaging alone cannot always determine whether a lymph node contains cancer.
Removing lymph nodes during VAMLA allows the tissue to undergo microscopic examination. The results can provide important information about the cancer’s stage.
VAMLA may also be considered as part of surgical treatment in selected patients, depending on the location and characteristics of the tumor and the overall treatment plan.
VAMLA for Lung Cancer Staging
Accurate staging helps doctors understand how far lung cancer has spread. Mediastinal lymph-node involvement can significantly affect treatment decisions.
For example, depending on the patient’s specific cancer stage and other clinical factors, treatment may involve:
- Surgery
- Chemotherapy
- Radiation therapy
- Immunotherapy
- Targeted therapy
- A combination of treatments
VAMLA can provide a more comprehensive pathological assessment of mediastinal lymph nodes than a limited biopsy because several lymph-node stations may be removed during the procedure.
VAMLA vs. Conventional Mediastinoscopy
Traditional mediastinoscopy is commonly used to obtain biopsies from selected mediastinal lymph nodes. VAMLA takes the concept further by enabling a more systematic removal of mediastinal lymphatic tissue.
The potential advantages of VAMLA include:
- More extensive lymph-node removal
- Access to multiple mediastinal lymph-node stations
- A larger amount of tissue for pathological assessment
- More systematic evaluation of mediastinal lymph nodes
- Minimally invasive access compared with an open chest operation
The appropriate procedure depends on the individual patient. Other techniques, including endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), endoscopic ultrasound-guided sampling, or surgical lymph-node dissection during lung resection, may also be appropriate in different circumstances.
Benefits of VAMLA
VAMLA offers several potential benefits when extensive mediastinal lymph-node assessment is required.
Minimally Invasive Access
The procedure is performed through a relatively small incision in the neck rather than requiring an open thoracic incision.
Comprehensive Lymph-Node Assessment
VAMLA can allow systematic dissection of multiple mediastinal lymph-node stations, providing extensive tissue for pathological examination.
Accurate Pathological Staging
Direct examination of removed lymph nodes can establish whether cancer cells are present and help determine the extent of disease.
Helps Guide Treatment
The pathological findings can contribute to decisions about whether a patient should proceed with surgery, systemic treatment, radiation, or another combination of therapies.
Risks and Possible Complications
Although VAMLA is minimally invasive, it is still a surgical procedure and carries potential risks.
Possible complications can include:
- Bleeding
- Infection
- Injury to nearby blood vessels
- Injury to the recurrent laryngeal nerve, which can affect the voice
- Injury to the trachea or esophagus
- Pneumothorax
- Anesthetic complications
- Postoperative pain or discomfort
The likelihood of complications varies according to the patient’s health, anatomy, cancer characteristics, and the experience of the surgical team.
Recovery After VAMLA
Recovery after VAMLA is generally shorter than recovery from major open chest surgery, although individual recovery times vary.
Patients may experience some discomfort around the incision in the lower neck. Temporary hoarseness or throat discomfort can also occur, particularly if structures near the laryngeal nerves are affected during surgery.
The surgical team will monitor the patient after the procedure and provide instructions regarding wound care, activity, medications, and follow-up appointments.
The removed lymph nodes are sent to a pathology laboratory. The pathology report is an important part of determining the cancer stage and planning subsequent treatment.
Who May Be Considered for VAMLA?
VAMLA may be considered for selected patients with suspected or confirmed lung cancer when comprehensive assessment or removal of mediastinal lymph nodes is required.
Whether VAMLA is appropriate depends on factors such as:
- Type of lung cancer
- Location and size of the primary tumor
- Findings from CT or PET imaging
- Suspected lymph-node involvement
- Previous diagnostic procedures
- Overall health
- Planned cancer treatment
A thoracic surgeon and multidisciplinary cancer team can determine the most appropriate approach after reviewing the patient’s imaging, pathology, and clinical history.
Conclusion
Video-Assisted Mediastinoscopic Lymphadenectomy (VAMLA) is a minimally invasive surgical technique that enables extensive removal and pathological examination of mediastinal lymph nodes through an incision in the neck. Its primary role is in the assessment and staging of lung cancer, where determining lymph-node involvement can have an important impact on treatment planning.
By providing surgeons with access to multiple mediastinal lymph-node stations, VAMLA can offer detailed pathological information while avoiding the larger incisions associated with open chest surgery. However, the procedure is not appropriate for every patient, and the choice between VAMLA and other diagnostic or surgical techniques should be based on the individual’s cancer characteristics and overall treatment plan.